Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 15
Submit an article Journal homepage
402
Views
18
CrossRef citations to date
0
Altmetric
Drug Evaluations

Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock

Andrea Morelli University of Rome – “La Sapienza”, Department of Anesthesiology and Intensive Care, Viale del Policlinico 155, Rome 00161, Italy +39 06 499 78024; +39 06 446 1967; [email protected]
, MD,
Christian Ertmer University Hospital of Muenster, Department of Anesthesiology and Intensive Care, Albert Schweitzer-Str. 33, Muenster 48149, Germany
, MD,
Paolo Pietropaoli University of Rome – “La Sapienza”, Department of Anesthesiology and Intensive Care, Viale del Policlinico 155, Rome 00161, Italy +39 06 499 78024; +39 06 446 1967; [email protected]
, MD &
Martin Westphal University Hospital of Muenster, Department of Anesthesiology and Intensive Care, Albert Schweitzer-Str. 33, Muenster 48149, Germany
, MD PhD
Pages 2569-2575 | Published online: 08 Sep 2009

Bibliography

  • Krag A, Borup T, Moller S, et al. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ther 2008;25:1105-40
  • Martin-Llahi M, Pepein MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008;134:1352-9
  • Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003;17:53-64
  • Boccara G, Ouattara A, Godet G, et al. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors. Anesthesiology 2003;98:1338-44
  • Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;23:588-95
  • Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
  • Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 2000;11:406-10
  • Maybauer MO, Maybauer DM, Enkhbaatar P, et al. Physiology of the vasopressin receptors. Best Pract Res Clin Anaesthesiol 2008;22:253-63
  • Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1 – receptor physiology. Crit Care 2003;7:427-34
  • Barret LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007;35:33-40
  • Pesaturo AB, Jennings HR, Voils SA. Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother 2006;40:2170-7
  • Forsling ML, Aziz LA, Miller M, et al. Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol 1980;85:237-44
  • Nilsson G, Lindblom P, Ohlin M, et al. Pharmakinetics of terlipressin after single i.v. doses to healthy volunteers. Drug Exp Clin Res 1990;16:307-14
  • Lange M, Ertmer C, Westphal M. Vasopressin vs terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 2008;34:821-32
  • Ryckwaert F, Virsolvy A, Fort A, et al. Terlipressin, a pro-vasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance. Crit Care Med 2009;37:876-81
  • Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-5
  • Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med 2003;31:1752-8
  • Scharte M, Meyer J, Van Aken H, et al. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001;29:1756-60
  • Asfar P, Pierrot M, Veal N, et al. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003;31:215-20
  • Lange M, Morelli A, Ertmer C, et al. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 2007;28:623-9
  • Westphal M, Stubbe H, Sielenkamper AW, et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003;29:301-8
  • O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10
  • Morelli A, Rocco M, Conti G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004;30:597-604
  • Albanese J, Leone M, Delmas A, et al. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005;33:1897-902
  • Leone M, Albanese J, Delmas A, et al. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004;22:314-19
  • Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001;29:487-93
  • Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, et al. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004;30:477-80
  • Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, et al. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 2006;10:R20
  • Zeballos G, Lopez-Herce J, Fernandez C, et al. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation 2006;68:151-3
  • Yildizdas D, Yapicioglu H, Celik U, et al. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 2008;34:511-17
  • Klein M, Weksler N, Borer A, et al. Terlipressin facilitates transport of septic patients treated with norepinephrine. Isr Med Assoc J 2006;8:691-3
  • Medel J, Boccara G, Van de Steen E, et al. Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 2001;93:53-5
  • Schmitt W, Wagner-Thiessen E, Lux G. Ischemic colitis in a patient treated with glypressin for bleeding oesophageal varices. Hepatogastrenterology 1987;34:134-6
  • Stephan F, Paillard F. Terlipressin-exacerbated hypokaliemia. Lancet 1998;351:1249-50
  • Donnelan F, Cullen G, Hegarty JE, et al. Ischemic complications of Glypressin in liver disease: a case series. Br J Clin Pharmacol 2007;64:550-2
  • Morelli A, Tritapepe L, Rocco M, et al. Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics. Anesthesiology 2005;102:12-9
  • Lauzier F, Lévy B, Lamarre P, et al. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2006;32:1782-9
  • Morelli A, Ertmer C, Lange M, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth 2008;100:494-503
  • Patel BM, Chittok DR, Russel JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-82
  • Dünser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 2003;107:2313-79
  • Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87
  • Singer M. Arginine vasopressin vs. terlipressin in the treatment of shock states. Best Pract Res Clin Anaesthesiol 2008;22:359-68
  • Rivers E, Nguyen B, Havstad S, et al. Early goal-Directed Therapy Collaborative Group: early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med 2001;345:1368-77
  • Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007;35:2016-24
  • Jolley DH, De Keulenaer BL, Potter A, et al. Terlipressin infusion in catecholamine-resistant shock. Anaesth Intensive Care 2003;31:560-4
  • Morelli A, Ertmer C, Lange M, et al. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med 2007;33:1669-70
  • Umgelter A, Reindl W, Schmid RM, et al. Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver. Intensive Care Med 2008;34:390-1
  • Morelli A, Ertmer C, Lange M, et al. Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study. Crit Care 2008;12(Suppl 2):P403
  • Asfar P, Hauser B, Ivanyi Z, et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 2005;33:373-80
  • Rehberg S, Ertmer C, Köhler G, et al. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock. Intensive Care Med 2009;35:1286-96
  • Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009;37:811-18
  • Annane D. Vasopressin plus corticosteroids: the shock duo! Crit Care Med 2009;37:1126-7
  • Traber D. Selective V1a receptor agonists in experimental septic shock. Crit Care 2007;11(Suppl 4):P51
  • Laporte R, Russell J, Landry D, et al. The selective V1a receptor agonist FE 202158 reverses platelet activating factor (PAF)-induced hypotension, vascular leak, impaired tissue perfusion, and mortality in rats. Crit Care 2008;12(Suppl 2):P407

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.